PATENT AND TRADEMARK OFFICE ISSUES NOTICE: GRANT OF INTERIM EXTENSION OF THE TERM OF U.S. PATENT NO. 7,319,099; BITOPERTIN (GLYT1 INHIBITOR) ORAL TABLETS

WASHINGTON, Dec. 10 -- Patent and Trademark Office has issued a notice called: Grant of Interim Extension of the Term of U.S. Patent No. 7, 319, 099; Bitopertin (GlyT1 inhibitor) Oral Tablets.

The notice was published in the Federal Register on Dec. 10 by Charles Kim, Deputy Commissioner for Patents, United States Patent and Trademark Office.

Summary: The United States Patent and Trademark Office has issued a certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 7, 319, 099 ('099 patent).

For more information, contact Ali Salimi, Senior Legal Advisor, Office of Patent Legal Administration, at 571-272-0909 or [e-mail]; or Andrea S. Grossman, Legal Advisor, Office of Patent Legal ...